Optimisation of combined therapy and clinico-laboratory control of children with bronchial asthma, using formoterol

Cover Page

Cite item

Full Text

Abstract

Searching for exact ways and scheme of treatment and supervising asthma patients on long-acting form of b 2-agonist (Formoterol) therapy is still very actual. We studied 31 children (from 7 to 11 years) with moderate non-controled bronchial asthma during 12 weeks. As a basic therapy inhaled corticosteroids-mono or in a combination with Foradyle were used. Corresponding data on Childhood Asthma Control Test, lung function, electrocardiogram, serum potassium and glucose concentrations were monitoring clinically. No adverse reactions were seen. The results obtained for the case of combined therapy with formoterol point out the necessity of more frequent than prescribed observation of the patient state trend, with taking electrocardiography and especially compliance into account.

About the authors

L V Puschko

Peoples' Friendship University of Russia

Department of Pediatrics

O V Alekseeva

Peoples' Friendship University of Russia

Department of Pediatrics

T V Brilkova

Peoples' Friendship University of Russia

Department of Pediatrics

T I Nazarova

Peoples' Friendship University of Russia

Department of Pediatrics

T B Oboladze

Peoples' Friendship University of Russia

Email: rudnvestnik@yandex.ru
Department of Pediatrics

E R Samitova

Morozov Children Hospital

References


Copyright (c) 2013 Пушко Л.В., Алексеева О.В., Брилькова Т.В., Назарова Т.И., Оболадзе Т.Б., Самитова Э.Р.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies